Introduction
Depression and anxiety disorders are among the most common mental health conditions globally. Antidepressant medications are essential in restoring neurotransmitter balance and improving mood, sleep, and quality of life.
At Nirvana Pharma, we distribute a wide range of antidepressants including SSRIs, SNRIs, TCAs, atypical antidepressants, and MAO inhibitors — ensuring comprehensive coverage for hospitals, clinics, and mental health providers.
📋 Antidepressant Product Catalogue
Selective Serotonin Reuptake Inhibitors (SSRIs)
| Drug Name |
Common Strengths |
Primary Uses |
| Fluoxetine |
Cap/Tab: 10, 20, 40 mg; Oral soln: 20 mg/5 mL |
Depression, OCD, bulimia, anxiety |
| Sertraline |
Tab: 25, 50, 100 mg |
Depression, PTSD, panic disorder |
| Paroxetine |
Tab: 10–40 mg; CR: 12.5, 25, 37.5 mg |
Depression, GAD, OCD, panic disorder |
| Citalopram |
Tab: 10, 20, 40 mg |
Depression |
| Escitalopram |
Tab: 5, 10, 20 mg; Oral drops: 20 mg/mL |
Depression, GAD, panic disorder |
| Fluvoxamine |
Tab: 25, 50, 100 mg |
Depression, OCD, anxiety |
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
| Drug Name |
Common Strengths |
Primary Uses |
| Venlafaxine |
Tab: 25–100 mg; XR: 37.5, 75, 150 mg |
Depression, GAD, panic disorder |
| Desvenlafaxine |
Tab: 50, 100 mg (XR) |
Depression |
| Duloxetine |
Cap: 20, 30, 40, 60 mg |
Depression, neuropathic pain, fibromyalgia |
| Levomilnacipran |
Cap: 20, 40, 80, 120 mg (ER) |
Major depressive disorder |
Tricyclic Antidepressants (TCAs)
| Drug Name |
Common Strengths |
Primary Uses |
| Amitriptyline |
Tab: 10–150 mg |
Depression, neuropathic pain, migraine prophylaxis |
| Nortriptyline |
Cap: 10, 25, 50, 75 mg |
Depression, smoking cessation aid |
| Imipramine |
Tab: 10, 25, 50 mg |
Depression, nocturnal enuresis |
| Clomipramine |
Tab: 25, 50, 75 mg |
OCD, depression |
| Doxepin |
Cap: 10–150 mg |
Depression, anxiety, insomnia |
| Desipramine |
Tab: 10–150 mg |
Depression |
Atypical Antidepressants & Novel Agents
| Drug Name |
Common Strengths |
Primary Uses |
| Bupropion |
Tab: 75, 100 mg; SR: 100, 150 mg; XL: 150, 300 mg |
Depression, smoking cessation, ADHD |
| Mirtazapine |
Tab: 7.5, 15, 30, 45 mg |
Depression, insomnia, appetite stimulant |
| Agomelatine |
Tab: 25, 50 mg |
Depression, sleep disturbance |
| Trazodone |
Tab: 50–300 mg |
Depression, insomnia |
| Vilazodone |
Tab: 10, 20, 40 mg |
Depression, anxiety |
| Vortioxetine |
Tab: 5, 10, 20 mg |
Depression, cognitive dysfunction in MDD |
Monoamine Oxidase Inhibitors (MAOIs)
| Drug Name |
Common Strengths |
Primary Uses |
| Phenelzine |
Tab: 15 mg |
Resistant depression, anxiety |
| Tranylcypromine |
Tab: 10 mg |
Atypical/resistant depression |
| Isocarboxazid |
Tab: 10 mg |
Depression (rare use) |
| Selegiline |
Transdermal patch: 6–12 mg/24 hr |
Depression, Parkinson’s disease |
Closing Note
Our antidepressant portfolio offers clinicians a wide selection of first-line SSRIs and SNRIs, second-line TCAs and atypical agents, and specialized MAOIs for treatment-resistant depression. Nirvana Pharma ensures authentic sourcing, compliance, and timely distribution to support mental health care providers and patients.
